Iphrofayela Yenkampani
Ebusweni be-COVID-19 ecekela phansi umhlaba, kusukela ngosuku lokuzalwa kwayo, i-Sharetry ithathe ukuhlanganiswa kwe-R&D, ukubhaliswa, ukukhiqiza, ukuthengisa, nezisetshenziswa zemakethe zemishini yezokwelapha kanye nemishini yokuxilonga ye-in vitro njengomthwalo wethu wemfanelo nomsebenzi ongenakugwenywa. .Ngaphandle kwalokho, i-Sharetry futhi iyibhizinisi lobuchwepheshe obuphezulu elingabhekana ngokuzethemba nezinselele namathuba angaziwa.
Ukuze sibone ushintsho kanye nenani elethwa isayensi, ubuchwepheshe, kanye nokuqanjwa kabusha, sisungule izikhungo eziningi ze-R & D kanye nezinkampani ezingaphansi eziphethwe ngokuphelele e-China nakwamanye amazwe ase-Asia eminyakeni emi-4, kanye nozakwethu abacishe babe ngama-200, ngaphansi Ubuholi bososayensi abasebasha abavelele abangaphezu kwe-100. Ngokusekelwe emithethweni, ezimisweni, nasezinhlelweni ezikhona, sakhe amadivaysi okuhlola ama-in vitro anolwazi olusha, oluzinzile, futhi alunselele enziwe ngendlela oyifisayo inkundla ye-Contract Manufacture (CMO), i-Contract Development Manufacture (CDMO), kanye ne-Contract Inkundla Yezindaba Zokulawula (CRAO).
Inkundla eyodwa ye-3C inikeza izixazululo ezinobulungiswa, ezisezingeni eliphezulu, nezisebenza kahle futhi isize amakhasimende angaphezu kwe-100 emhlabeni jikelele, ehlanganisa i-immunofluorescence, i-biochemistry, amaprotheni athile, i-coagulation, i-COVID-19, ukuhlolwa kwezilwane ezifuywayo, ukuhlolwa kwezidakamizwa, ukuhlolwa okusheshayo, kanye test ekhaya.
Sihlinzeke ngokuphumelelayo ngemikhiqizo yekhwalithi ephezulu engaphezu kuka-300 futhi i-Sharetry isikhule yaba abahlinzeki abahamba phambili emhlabeni bezixazululo ze-3C zesitophu esisodwa samadivayisi okuxilongwa kwe-in vitro.Ngenkathi sihlinzeka ngobuchwepheshe nezinsizakalo zekhwalithi ephezulu, sithuthukise amakhithi okuhlola obuningi be-autoantibody angaphezu kwe-100, amakhithi okuhlola izinto ezingezwani nomzimba angu-55, amakhithi okuhlola ama-thrombus angu-6, kanye namakhithi okuhlola angu-14 e-POCT asekelwe ezisekelweni ze-chemiluminescence.Sithole izitifiketi zokubhaliswa ezingama-97 zemishini yezokwelapha Yesigaba II kwa-NMPA futhi imikhiqizo engaphezu kuka-400 imakwe njenge-CE.I-Sharetry isiyibhizinisi elihamba phambili e-China ngisho nase-Asia emkhakheni we-autoantibody kanye nokutholwa kokungezwani komzimba.
Ukuze sibhekane ngesikhathi nezinselele namathuba, sithuthukise ngokuzimela izinto ezingavuthiwe ezibaluleke kakhulu ezingaphezu kwezingu-20 zama-IVD reagents (ikakhulukazi ama-autoimmune antigen kanye nezingxenye zokungezwani komzimba), ezisetshenziswe kabanzi ekuthuthukisweni kwemishini yokuhlola.Sinamathisela ukubaluleka okukhulu kumalungelo empahla yobuhlakani futhi sithole amalungelo obunikazi kazwelonke angama-28, amalungelo okushicilela angama-software angu-8, amalungelo obunikazi angamamodeli angu-15, okusunguliwe oku-1, ilungelo lobunikazi, kanye namalungelo obunikazi okubukeka angu-4.Ngaphezu kwalokho, amalungelo obunikazi angama-31 (okuhlanganisa nama-patent angama-22) ayabuyekezwa.
Sithatha ukusungula izinto ezintsha njengomthwalo wethu, kanye "nendawo yokuqala ephezulu, izindinganiso eziqinile" njengenqubomgomo yethu yentuthuko, sihlala sinamathela emisha, sinamathela ku-R & D yobuchwepheshe, ngombono "wokuba yibhizinisi lokuxilonga elihamba phambili emhlabeni jikelele le-in-vitro. ", ukuthekelisa izinsiza ezisezingeni eliphezulu kanye nemikhiqizo yokuxilonga emhlabeni, futhi unakekele impilo yesiguli.
I-Factory Tour
Ozakwethu
